1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Malaysia Pharmaceuticals and Healthcare Report Q2 2016

Malaysia Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 101 pages

Includes 3 FREE quarterly updates

BMI View: We hold a bullish outlook for Malaysia's pharmaceutical market over our forecast period. Webelieve the government's commitment to expanding healthcare access coupled with the country's growingpopulation and disease burden will drive medicine demand in the coming years. Furthermore, the signing ofthe Trans-Pacific Partnership (TPP) agreement - after years of negotiation and uncertainty - will work tostrengthen multinational interest in the market, particularly patented drug manufacturers.

Headline Expenditure Projections

- Pharmaceuticals: MYR7.88bn (USD2.02bn) in 2015 to MYR8.59bn (USD2.05bn) in 2016; +9.0% inlocal currency and +1.4% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: MYR45.85bn (USD11.73bn) in 2015 to MYR49.38bn (USD11.77bn) in 2016; +7.7% inlocal currency and +0.2% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Malaysia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Malaysia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020) 21
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020) 26
OTC Medicine Market Forecast 27
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2014-2020) 32
Industry Risk/Reward Index 33
Asia Pacific Risk/Reward Index 33
Malaysia Risk/Reward Index 39
Rewards 39
Risks 39
Market Overview 41
Epidemiology 41
Healthcare Sector 43
Table: 2011 Entry Point Projects Summary 45
Table: Healthcare Resources (Malaysia 2010-2015) 46
Table: Healthcare Personnel (Malaysia 2010-2015) 46
Table: Healthcare Activity (Malaysia 2010-2015) 47
Healthcare Insurance 47
Table: Main Features Of 1Care 47
Healthcare Funding 49
Healthcare Sector Developments 50
Table: Public Sector And Private Sector Healthcare Developments 50
Medical Tourism 51
Research and Development 52
Clinical Trials 54
Regulatory Review 55
Regulatory Regime 55
Table: Drug Applications by Type, 2002-2010 57
Table: Registered Pharmaceutical Products by Type, 2002-2010 57
Regulatory Developments 57
Intellectual Property Issues 62
Pricing Regime 66
Competitive Landscape 68
Domestic Industry 68
Foreign Industry 71
Table: Table: Multinational Market Activity 72
Table: Leading Malaysian Pharmaceutical And Healthcare Companies 73
Culture-Specific Medicines 73
Pharmaceutical Distribution 75
Table: Drug Wholesalers and Importers, 2002-2010 76
Pharmaceutical Retail Sector 76
Company Profile 79
Chemical Company Of Malaysia 79
Kotra Pharma 82
Novartis 84
Ranbaxy Malaysia 86
Sanofi 88
Demographic Forecast 90
Table: Population Headline Indicators (Malaysia 1990-2025) 91
Table: Key Population Ratios (Malaysia 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Malaysia 1990-2025) 92
Table: Population By Age Group (Malaysia 1990-2025) 92
Table: Population By Age Group % (Malaysia 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.